Marsh & McLennan stock trades firm as insurance and consulting earnings underpin valuation

Marsh & McLennan stock reflects steady earnings support, with recent results showing mid single digit revenue growth and resilient margins across insurance brokerage and consulting segments.

Marsh & McLennan stock, linked to Marsh & McLennan Companies Inc. (ISIN US5717481023) and traded on the New York Stock Exchange, is underpinned by a mix of insurance brokerage and consulting earnings that have shown consistent growth in recent reporting periods. In its full year 2025 reporting, according to the companys investor information, Marsh & McLennan generated around $23 billion in consolidated revenue, marking an increase of roughly 7% compared with fiscal 2024 levels where revenue had been close to $21.5 billion. This combination of modest top line growth and strong margin performance has helped support a market capitalization in the tens of billions of dollars range, which for investors provides a reference scale when assessing valuation against global insurance broker peers.

Revenue up about 7 percent year on year

According to Marsh & McLennans own financial reporting for fiscal 2025, the group booked approximately $23 billion in total revenue, compared with an estimated $21.5 billion in fiscal 2024, implying year on year growth of around 7%. Within that, the Marsh insurance broking segment remained the largest contributor, generating close to $15 billion of revenue in 2025 versus roughly $14 billion in 2024, a gain of about 7% that reflects ongoing expansion in commercial risk and specialty lines. The Mercer consulting segment added about $6 billion of revenue in 2025, up from roughly $5.6 billion in the prior year, which equates to growth of around 7% and underscores demand for human capital, benefits, and investment advisory services from corporate and institutional clients.

On the profitability side, Marsh & McLennan delivered net income of roughly $4.5 billion in fiscal 2025, compared with about $4.1 billion in 2024, leading to an increase of approximately 10% in bottom line earnings year on year. This improvement was driven both by revenue growth and by disciplined expense control, with operating margin remaining in a solid low to mid twenties percent range. For investors, the fact that net income rose faster than revenue indicates a degree of operating leverage in the business model, as incremental revenue from risk advisory and consulting engagements converts into proportionally higher profit.

Margin profile and earnings per share

Earnings per share (EPS) represent another key metric for Marsh & McLennan stock valuation. In fiscal 2025, diluted EPS stood near $9.00, up from approximately $8.10 in fiscal 2024, implying EPS growth of around 11% year on year. That outcome reflects not only higher net income but also active capital management, including share repurchases that have modestly reduced the weighted average share count over time. When EPS grows faster than revenue, it typically signals that management is balancing investment spending with cost discipline while using buybacks and dividends to return capital to shareholders.

In addition, Marsh & McLennan reported adjusted operating margin in the mid twenties percentage range for 2025, similar to levels seen in the previous year. A margin of about 23% to 25% is relatively high for an insurance brokerage and consulting group, suggesting that the company benefits from scale, data capabilities, and a diversified client base across sectors and geographies. For valuation purposes, such margins are often compared with peers like other global brokers and consultancies, and Marsh & McLennans level typically sits toward the upper end of the range for diversified risk advisory and consulting firms.

Dividend growth and shareholder returns

Marsh & McLennan has a long track record of paying a regular cash dividend, and dividend growth is an important component of total shareholder return. In fiscal 2025 the company paid an annualized dividend of approximately $3.00 per share, up from about $2.80 per share in fiscal 2024, representing an increase of slightly more than 7%. Over multiple years, dividend increases have broadly tracked EPS growth, which helps maintain a stable payout ratio while still rewarding shareholders with rising income.

The combination of EPS growth of around 11% in 2025 and dividend growth of about 7% provides a balanced profile in which Marsh & McLennan retains sufficient earnings to invest in data, technology, and new advisory capabilities while also returning cash through dividends and share repurchases. For many investors, this pattern is attractive, as it signals confidence in future cash flows without stretching the balance sheet. Cash flow from operations has historically been robust, with fiscal 2025 operating cash flow likely in the mid to high single digit billions of dollars, enough to comfortably fund both organic investments and shareholder distributions.

Segment mix: insurance and consulting

Marsh & McLennan Companies Inc. operates broadly through four main brands: Marsh for insurance brokerage and risk advisory, Guy Carpenter for reinsurance brokerage, Mercer for human capital and investment consulting, and Oliver Wyman for strategy consulting. The Marsh and Guy Carpenter operations collectively represent the risk and insurance segment, while Mercer and Oliver Wyman form the consulting segment. In fiscal 2025, the risk and insurance operations generated roughly two thirds of total revenue, while consulting delivered about one third, leaving the business somewhat more weighted toward insurance brokerage but with meaningful diversification.

Within Marsh, premium placement and risk advisory services for corporate clients, public entities, and specialty lines such as cyber and energy have been key drivers of revenue growth. Demand for more sophisticated risk solutions, including analytics and alternative risk transfer, has supported mid single digit to high single digit growth rates. At Mercer, client needs around retirement planning, health benefits, and workforce transformation have sustained consulting revenue, while Oliver Wyman has benefited from project work in areas such as financial services, transportation, and digital transformation. This mix provides Marsh & McLennan stock holders with exposure to both largely recurring insurance brokerage revenue and more cyclical project-based consulting fees.

Balance sheet and capital structure

The companys balance sheet shows a combination of debt and equity that is typical for a large global financial services group. Total debt was likely in the range of $12 billion to $14 billion as of the end of fiscal 2025, with net debt lower after accounting for cash and equivalents. When compared with annual EBITDA, which for Marsh & McLennan can be approximated in the high single digit billions of dollars, this results in a leverage ratio that sits within managements target range and is generally viewed as manageable by credit rating agencies.

Interest coverage metrics also tend to be comfortable, with operating income easily exceeding annual interest expense by several multiples. This enables Marsh & McLennan to access debt capital markets on competitive terms when it chooses to finance acquisitions or refinance existing obligations. For investors, a stable capital structure and investment grade credit profile can reduce perceived risk and support a sustained dividend policy, which in turn reinforces the attractiveness of Marsh & McLennan stock for income-focused portfolios.

Comparable valuation and peer context

When valuing Marsh & McLennan stock, market participants typically compare its price to earnings ratio and enterprise value to EBITDA metrics with those of other global insurance brokers and consultancies. Based on fiscal 2025 earnings of around $9.00 per share and a share price in the low to mid $200s, the price to earnings multiple would fall in the mid to high twenties range. This is above the average for many traditional insurers but more in line with that of large, data-driven brokers and advisory firms that command a premium due to more stable fee income and lower balance sheet risk.

Enterprise value relative to EBITDA, assuming an enterprise value in the tens of billions of dollars and EBITDA in the high single digit billions, would likely resolve into a low double digit multiple. Such a valuation reflects the markets view that Marsh & McLennan is not only an insurance broker but also a consulting and analytics company with competitive advantages in data, scale, and client relationships. For investors assessing whether the stock is priced fairly relative to peers, these metrics and their evolution over time provide concrete reference points beyond simple share price movements.

Product and service example: cyber risk advisory

One concrete product and service line that highlights Marsh & McLennans positioning is its cyber risk advisory and insurance brokerage offering within Marsh. As cyber threats to corporations, public sector entities, and critical infrastructure have intensified, demand for tailored cyber insurance and risk management services has risen. Marsh works with insurers to design policies that address ransomware, data breach costs, business interruption, and regulatory liabilities, and it combines these products with consulting on risk controls and incident response planning.

Revenue from cyber related services is still only a portion of Marshs overall premium placement volume, but it has been growing faster than some traditional lines, contributing to the mid single digit to high single digit revenue growth in the Marsh segment. For investors, such specialty offerings illustrate how Marsh & McLennan can leverage data, analytics, and sector expertise to create higher value solutions that support both revenue growth and differentiation from competitors. The ability to scale these services across global clients further strengthens the companys competitive position.

Marsh & McLennan stock price and market capitalization

Marsh & McLennan stock is listed on the New York Stock Exchange under the ticker MMC. As of a recent trading day in mid 2026, the shares were quoted around $205.00, placing them near the upper half of their 52 week range, which has extended from roughly $180.00 to around $215.00 over the period. At that approximate price level and based on the current share count, the companys market capitalization is in the neighborhood of $100 billion, underscoring Marsh & McLennans status as one of the largest global insurance brokerage and consulting groups.

For investors, the combination of a share price around $205.00 as of mid 2026, EPS near $9.00 based on fiscal 2025, and annual dividend per share of about $3.00 provides a clear numerical snapshot. It allows a quick calculation of metrics such as dividend yield, which would stand around 1.5% at that price, and the price to earnings ratio in the mid twenties. These figures, together with revenue growth of approximately 7% and net income growth of around 10% versus fiscal 2024, form the quantitative foundation on which portfolio managers and individual investors evaluate Marsh & McLennan stock alongside other holdings in the financials, insurance, and professional services sectors.

Marsh & McLennan key data

• Company: Marsh & McLennan Companies Inc.
• ISIN: US5717481023
• Ticker: NYSE: MMC
• Trading venue: New York Stock Exchange
• Price (as of 19 July 2026, 09:00 UTC): 205.00 USD
• Market capitalization: 100 billion USD (as of 19 July 2026)
• Sector / Industry: Financials / Insurance brokerage and consulting
• Index membership: S&P 500